Proteostasis Therapeutics Garners $5,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=927a4ca1-d4a8-4f58-ad51-caae2d48792b - Date
10/8/2014 - Company Name
Proteostasis Therapeutics - Mailing Address
200 Technology Square 4th Floor Cambridge, MA 02139 USA - Company Description
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases. - Website
http://www.proteostasis.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
